Drug maker AFT climbs 11% in NZX debut

Drug maker AFT climbs 11% in NZX debut
Fiona Rotherham
By Fiona Rotherham Dec. 22 (BusinessDesk) - AFT Pharmaceuticals gained 11 percent on the Auckland-based drug-maker's NZX debut after a $35.6 million initial public offering – only the fourth on the local bourse this year. AFT’s shares first traded at $3.12, valuing the company at $302 million, after being sold in the IPO at $2.80 apiece. It has dual-listed on the NZX and ASX. It last traded at $3.10. NZX boss Tim Bennett recently bemoaned the lacklustre number of IPOs this year with the four, which includes two compliance listings, com...